标题
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-07-28
DOI
10.3389/fendo.2020.00474
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia
- (2020) Tianhua Zhang et al. CLINICAL BIOCHEMISTRY
- Nucleic Acid–Based Therapies for Atherosclerosis
- (2020) Petri Mäkinen et al. Current Atherosclerosis Reports
- ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis
- (2020) Romain Capoulade et al. HEART
- Dual apoC-II mimetic and apoC-III antagonist for hypertriglyceridaemia
- (2020) Karina Huynh Nature Reviews Cardiology
- A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides
- (2020) Anna Wolska et al. Science Translational Medicine
- Apolipoprotein C-II
- (2020) Anna Wolska et al. CURRENT OPINION IN LIPIDOLOGY
- The next generation of triglyceride-lowering drugs
- (2020) Laurens F. Reeskamp et al. CURRENT OPINION IN LIPIDOLOGY
- Apolipoprotein C-III Strongly Correlates with Activated Factor VII–Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation
- (2019) Marcello Baroni et al. THROMBOSIS AND HAEMOSTASIS
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia
- (2019) Martin Adiels et al. DIABETES OBESITY & METABOLISM
- N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
- (2019) Veronica J Alexander et al. EUROPEAN HEART JOURNAL
- ApoC-III ASO Promotes Tissue LPL Activity in Absence of ApoE-Mediated TRL Clearance
- (2019) Bastian Ramms et al. JOURNAL OF LIPID RESEARCH
- Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans
- (2019) Bettina Hieronimus et al. Journal of Clinical Medicine
- Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
- (2019) Jenny E. Kanter et al. JOURNAL OF CLINICAL INVESTIGATION
- Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?
- (2019) Henry N. Ginsberg et al. JOURNAL OF CLINICAL INVESTIGATION
- ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors
- (2019) Natalie C. Kegulian et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Dietary Fructose and the Metabolic Syndrome
- (2019) Taskinen et al. Nutrients
- Dietary fructose and dyslipidemia
- (2019) Bettina Hieronimus et al. CURRENT OPINION IN LIPIDOLOGY
- Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII
- (2019) Oliviero Olivieri et al. STROKE
- APOC3Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular RiskHighlights
- (2018) Anders B. Wulff et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- RNA-Targeted Therapeutics
- (2018) Stanley T. Crooke et al. Cell Metabolism
- An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans
- (2018) Adil Mardinoglu et al. Cell Metabolism
- Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism
- (2018) Bastian Ramms et al. CURRENT OPINION IN LIPIDOLOGY
- Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths
- (2018) Maija Ruuth et al. EUROPEAN HEART JOURNAL
- Treatment with Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients with FCS and sHTG vs Placebo: Results of the APPROACH and COMPASS †
- (2018) Andres Gelrud et al. Journal of Clinical Lipidology
- Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials
- (2018) Amirhossein Sahebkar et al. Journal of Clinical Lipidology
- GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
- (2018) Aaron D. Springer et al. Nucleic Acid Therapeutics
- Broad Views of Non-alcoholic Fatty Liver Disease
- (2018) Adil Mardinoglu et al. Cell Systems
- Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial
- (2018) Jeremy D Furtado et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials
- (2018) Amirhossein Sahebkar et al. ANNALS OF MEDICINE
- Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism
- (2018) Gissette Reyes-Soffer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program
- (2018) Derek Klarin et al. NATURE GENETICS
- Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity
- (2017) Jean-Marc Schwarz et al. GASTROENTEROLOGY
- Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions
- (2017) Saulo Mendoza et al. Journal of Clinical Lipidology
- Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity
- (2017) M.-R. Taskinen et al. JOURNAL OF INTERNAL MEDICINE
- Using primary murine intestinal enteroids to study dietary TAG absorption, lipoprotein synthesis, and the role of apoC-III in the intestine
- (2017) Javeed Jattan et al. JOURNAL OF LIPID RESEARCH
- The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation
- (2017) Meenakshi Sundaram et al. JOURNAL OF LIPID RESEARCH
- Aromatic residues in the C terminus of apolipoprotein C-III mediate lipid binding and LPL inhibition
- (2017) Nathan L. Meyers et al. JOURNAL OF LIPID RESEARCH
- Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review
- (2017) Jan Oscarsson et al. Lipids in Health and Disease
- Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity
- (2017) Danish Saleheen et al. NATURE
- Exome-wide association study of plasma lipids in >300,000 individuals
- (2017) Dajiang J Liu et al. NATURE GENETICS
- Increasing Lipolysis and Reducing Atherosclerosis
- (2017) Alan R. Tall NEW ENGLAND JOURNAL OF MEDICINE
- Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
- (2016) Marja-Riitta Taskinen et al. Current Atherosclerosis Reports
- Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
- (2016) Andres Digenio et al. DIABETES CARE
- ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
- (2016) Philip L.S.M. Gordts et al. JOURNAL OF CLINICAL INVESTIGATION
- The effect of omega-3 carboxylic acids on apolipoprotein CIII−containing lipoproteins in severe hypertriglyceridemia
- (2016) Allyson M. Morton et al. Journal of Clinical Lipidology
- Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes
- (2016) Juraj Koska et al. JOURNAL OF LIPID RESEARCH
- A dose-response study of consuming high-fructose corn syrup–sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults
- (2015) Kimber L Stanhope et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal ObesitySignificance
- (2015) Jan Borén et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New insights into the pathophysiology of dyslipidemia in type 2 diabetes
- (2015) Marja-Riitta Taskinen et al. ATHEROSCLEROSIS
- The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
- (2015) Frank M. Sacks CURRENT OPINION IN LIPIDOLOGY
- The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis
- (2015) Moritz C. Wyler von Ballmoos et al. Journal of Clinical Lipidology
- Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial
- (2015) Richard L. Dunbar et al. Lipids in Health and Disease
- Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms
- (2015) Olgica Trenchevska et al. METHODS
- Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
- (2015) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes
- (2015) Karin Åvall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Apolipoprotein C-III: From Pathophysiology to Pharmacology
- (2015) Giuseppe Danilo Norata et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Apolipoprotein C-III
- (2015) Alison B. Kohan Current Opinion in Endocrinology Diabetes and Obesity
- The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides
- (2015) Hussein N. Yassine et al. PLoS One
- Rare Variant APOC3 R19X Is Associated With Cardio-Protective Profiles in a Diverse Population-Based Survey as Part of the Epidemiologic Architecture for Genes Linked to Environment Study
- (2014) D. C. Crawford et al. Circulation-Cardiovascular Genetics
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families
- (2013) A.E. Bochem et al. CLINICAL GENETICS
- Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid Droplets
- (2013) Mikael Larsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates
- (2013) Ioanna Tachmazidou et al. Nature Communications
- Implementing a successful data-management framework: the UK10K managed access model
- (2013) Dawn Muddyman et al. Genome Medicine
- Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial
- (2012) G. Reyes-Soffer et al. DIABETES CARE
- Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men
- (2012) N Faghihnia et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- 32 TRIGLYCERIDE-RICH LIPOPROTEINS AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN PATIENTS AT HIGH RISK OF CARDIOVASCULAR DISEASE: EVIDENCE AND GUIDANCE FOR MANAGEMENT
- (2011) M.J. Chapman et al. ATHEROSCLEROSIS SUPPLEMENTS
- Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia
- (2011) Kevin C. Maki et al. Journal of Clinical Lipidology
- Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease
- (2011) Esther M. M. Ooi et al. JOURNAL OF LIPID RESEARCH
- Silencing disease genes in the laboratory and the clinic
- (2011) Jonathan K Watts et al. JOURNAL OF PATHOLOGY
- Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia
- (2010) Sandrine Caron et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Regulation of Hepatic ApoC3 Expression by PGC-1β Mediates Hypolipidemic Effect of Nicotinic Acid
- (2010) Carlos Hernandez et al. Cell Metabolism
- Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype
- (2010) Chunyu Zheng et al. CIRCULATION
- ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
- (2009) A. Hiukka et al. DIABETES
- Triglyceride-Rich Lipoprotein-Associated Apolipoprotein C-III Production Is Stimulated by Plasma Free Fatty Acids in Humans
- (2008) Mirjana Pavlic et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Atorvastatin and Fenofibrate Have Comparable Effects on VLDL-Apolipoprotein C-III Kinetics in Men With the Metabolic Syndrome
- (2008) Dick C. Chan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome
- (2008) Martin Adiels et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
- (2008) Esther M. M. Ooi et al. CLINICAL SCIENCE
- Fatty liver, insulin resistance, and dyslipidemia
- (2008) Martin Adiels et al. Current Diabetes Reports
- Dose-Dependent Effect of Rosuvastatin on VLDL-Apolipoprotein C-III Kinetics in the Metabolic Syndrome
- (2008) E. M.M. Ooi et al. DIABETES CARE
- Structure and Dynamics of Human Apolipoprotein CIII
- (2008) Chinthaka Saneth Gangabadage et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular processes that handle — and mishandle — dietary lipids
- (2008) Kevin Jon Williams JOURNAL OF CLINICAL INVESTIGATION
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
- (2008) T. I. Pollin et al. SCIENCE
- Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance
- (2007) Herbert Schuster et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started